Lupus Aortitis Successfully Treated with Moderate-dose Glucocorticoids: A Case Report and Review of the Literature

Intern Med. 2020 Nov 1;59(21):2789-2795. doi: 10.2169/internalmedicine.4964-20. Epub 2020 Jul 7.

Abstract

Lupus aortitis is a rare and potentially life-threatening disorder. Previous studies have reported the utility of high-dose systemic glucocorticoids or surgery as the treatment, although there have been no related controlled trials. We herein report a 49-year-old woman with a 35-year history of systemic lupus erythematosus who was diagnosed with aortitis. Her symptoms and laboratory and imaging abnormalities rapidly resolved upon the administration of moderate-dose glucocorticoids. We subsequently performed a literature review of similar cases to identify the appropriate treatment and discuss these cases. A study of further cases will be needed to identify the characteristics of patients who would benefit from moderate-dose glucocorticoid therapy.

Keywords: lupus aortitis; moderate-dose glucocorticoid therapy; systemic lupus erythematosus.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aortitis / diagnosis
  • Aortitis / drug therapy*
  • Aortitis / etiology*
  • Aortitis / physiopathology*
  • Child
  • Dose-Response Relationship, Drug*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Male
  • Middle Aged
  • Treatment Outcome
  • Young Adult

Substances

  • Glucocorticoids